Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Can Cibus Cbus Stock Reach New Highs Price At 2.02 Up 2.02 20260406 Will Erasca Eras Stock Recover Soon Price At 18.04 Up 1.26 20260406 What Is The Growth Rate Of China Natres Chnr Stock Price At 3.72 Down 4.62 20260409 Huawei Eyes New Smartphone Chips This Fall as Tech Rivalry Intensifies Trump Discloses 1M5M Stake in Kura Sushi USA Despite Personal Aversion to Raw Fish Boston Scientific Shares Decline After Reiterating FullYear Growth Outlook Amazons Potential Path to 20 Appreciation A Cautious Look at Key Drivers Bloom Energy Partners With European AI Infrastructure Firm Nebius in 26 Billion Deal Shares Jump Microsofts New Responsible Tech Lead Navigates Tension Between AI Speed and Trustworthy Development FINV Q1 2026 Earnings EPS of 1764126 Drives Stock Surge Despite Missing Revenue Context PENN Q1 2026 Earnings EPS Miss Widens as Costs Pressure Margins Shares Edge Higher BBT Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Quarter SHEL Q1 2026 Earnings Strong EPS Beat Helped by Robust Operations Stock Edges Lower PYXS Q1 2026 Earnings BetterthanExpected Loss Highlights Progress in Oncology Pipeline Sensei Biotherapeutics Inc SNSE Q1 2026 Earnings Deep EPS Miss Reflects Heavy RD Investment and PreRevenue Status Prudential Financial PRS Holds Steady at 2252 Amid Stable Trading Ironwood Pharmaceuticals IRWD Edges Higher Can It Hold Above Key Support MPLX Declines 135 Assessing Support and Resistance Levels Robinhood Markets HOOD Surges Over 11 as Bullish Momentum Builds Transdigm Group Holds Steady Near 1213 as Aerospace Demand Provides Support LGL Group Q1 2026 Earnings Significant EPS Miss Marked by 11989 Surprise TPG Q1 2026 Earnings EPS Beats Estimates by 14 Stock Edges Lower CRS Q1 2026 Earnings EPS Beats Estimates by 408 Stock Shows Modest Uptick AMTD Q4 2020 Earnings EPS Surges Past Estimates by 8093 BBLG Q1 2026 Earnings NarrowerthanExpected Loss as Bone Biologics Advances Development KSCP Q1 2026 Earnings Wider Loss Weighs on Sentiment as Stock Climbs